189 related articles for article (PubMed ID: 19740658)
1. Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.
Andrews M; Brown A; Chiva JY; Fradet D; Gordon D; Lansdell M; MacKenny M
Bioorg Med Chem Lett; 2009 Oct; 19(20):5893-7. PubMed ID: 19740658
[TBL] [Abstract][Full Text] [Related]
2. 1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: further insights into a class of triple re-uptake inhibitors.
Micheli F; Cavanni P; Bettati M; Bonanomi G; Di Fabio R; Fazzolari E; Marchioro C; Roscic M; Tarsi L; Visentini F; Zonzini L; Worby A
Bioorg Med Chem; 2011 Jun; 19(11):3451-61. PubMed ID: 21550808
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.
Park JE; Song C; Choi K; Sim T; Moon B; Roh EJ
Bioorg Med Chem Lett; 2013 Oct; 23(20):5515-8. PubMed ID: 24012181
[TBL] [Abstract][Full Text] [Related]
4. Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.
Andrews M; Brown A; Chiva JY; Fradet D; Gordon D; Lansdell M; MacKenny M
Bioorg Med Chem Lett; 2009 Apr; 19(8):2329-32. PubMed ID: 19282174
[TBL] [Abstract][Full Text] [Related]
5. Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin and norepinephrine reuptake.
Boot JR; Brace G; Delatour CL; Dezutter N; Fairhurst J; Findlay J; Gallagher PT; Hoes I; Mahadevan S; Mitchell SN; Rathmell RE; Richards SJ; Simmonds RG; Wallace L; Whatton MA
Bioorg Med Chem Lett; 2004 Nov; 14(21):5395-9. PubMed ID: 15454233
[TBL] [Abstract][Full Text] [Related]
6. 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.
Meltzer PC; Butler D; Deschamps JR; Madras BK
J Med Chem; 2006 Feb; 49(4):1420-32. PubMed ID: 16480278
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.
Shao L; Ma J; Wang F; Malcolm SC; Hewitt MC; Campbell UC; Spicer NA; Hardy LW; Schreiber R; Spear KL; Varney MA
Bioorg Med Chem Lett; 2011 Jan; 21(1):520-3. PubMed ID: 21095126
[TBL] [Abstract][Full Text] [Related]
8. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
Orjales A; Mosquera R; Toledo A; Pumar MC; García N; Cortizo L; Labeaga L; Innerárity A
J Med Chem; 2003 Dec; 46(25):5512-32. PubMed ID: 14640559
[TBL] [Abstract][Full Text] [Related]
9. Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors.
Wen H; Qin W; Yang G; Guo Y
Molecules; 2019 Jan; 24(3):. PubMed ID: 30704101
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.
Gong PK; Blough BE; Brieaddy LE; Huang X; Kuhar MJ; Navarro HA; Carroll FI
J Med Chem; 2007 Jul; 50(15):3686-95. PubMed ID: 17602602
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and inhibitory evaluation of 3-linked imipramines for the exploration of the S2 site of the human serotonin transporter.
Brinkø A; Larsen MT; Koldsø H; Besenbacher L; Kolind A; Schiøtt B; Sinning S; Jensen HH
Bioorg Med Chem; 2016 Jun; 24(12):2725-38. PubMed ID: 27160055
[TBL] [Abstract][Full Text] [Related]
12. 4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.
Pechulis AD; Beck JP; Curry MA; Wolf MA; Harms AE; Xi N; Opalka C; Sweet MP; Yang Z; Vellekoop AS; Klos AM; Crocker PJ; Hassler C; Laws M; Kitchen DB; Smith MA; Olson RE; Liu S; Molino BF
Bioorg Med Chem Lett; 2012 Dec; 22(23):7219-22. PubMed ID: 23084899
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antidepressant evaluation and docking studies of long-chain alkylnitroquipazines as serotonin transporter inhibitors.
Gabrielsen M; Wołosewicz K; Zawadzka A; Kossakowski J; Nowak G; Wolak M; Stachowicz K; Siwek A; Ravna AW; Kufareva I; Kozerski L; Bednarek E; Sitkowski J; Bocian W; Abagyan R; Bojarski AJ; Sylte I; Chilmonczyk Z
Chem Biol Drug Des; 2013 Jun; 81(6):695-706. PubMed ID: 23574807
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.
Greiner E; Boos TL; Prisinzano TE; De Martino MG; Zeglis B; Dersch CM; Marcus J; Partilla JS; Rothman RB; Jacobson AE; Rice KC
J Med Chem; 2006 Mar; 49(5):1766-72. PubMed ID: 16509591
[TBL] [Abstract][Full Text] [Related]
15. First dual NK(1) antagonists-serotonin reuptake inhibitors: synthesis and SAR of a new class of potential antidepressants.
Ryckmans T; Balançon L; Berton O; Genicot C; Lamberty Y; Lallemand B; Pasau P; Pirlot N; Quéré L; Talaga P
Bioorg Med Chem Lett; 2002 Jan; 12(2):261-4. PubMed ID: 11755367
[TBL] [Abstract][Full Text] [Related]
16. Future directions for serotonin and antidepressants.
Artigas F
ACS Chem Neurosci; 2013 Jan; 4(1):5-8. PubMed ID: 23336036
[TBL] [Abstract][Full Text] [Related]
17. 2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.
Voelker T; Xia H; Fandrick K; Johnson R; Janowsky A; Cashman JR
Bioorg Med Chem; 2009 Mar; 17(5):2047-68. PubMed ID: 19201198
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Indazoles as Potent, Orally Active Dual Neurokinin 1 Receptor Antagonists and Serotonin Transporter Inhibitors for the Treatment of Depression.
Degnan AP; Tora GO; Huang H; Conlon DA; Davis CD; Hanumegowda UM; Hou X; Hsiao Y; Hu J; Krause R; Li YW; Newton AE; Pieschl RL; Raybon J; Rosner T; Sun JH; Taber MT; Taylor SJ; Wong MK; Zhang H; Lodge NJ; Bronson JJ; Macor JE; Gillman KW
ACS Chem Neurosci; 2016 Dec; 7(12):1635-1640. PubMed ID: 27744678
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.
Carroll FI; Blough BE; Abraham P; Mills AC; Holleman JA; Wolckenhauer SA; Decker AM; Landavazo A; McElroy KT; Navarro HA; Gatch MB; Forster MJ
J Med Chem; 2009 Nov; 52(21):6768-81. PubMed ID: 19821577
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME
PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]